INTERNATIONAL PATENT: TAVOTEK LAB INC, TAVOTEK BIOTHERAPEUTICS (HONG KONG) LIMITED FILES APPLICATION FOR "ANTIBODIES TARGETING CD318 (CDCP1) AND USES THEREOF"

GENEVA, Oct. 1 -- TAVOTEK LAB INC (727 Norristown Rd,3 Spring House Innovation Park, Suite 101Lower Gwynedd, Pennsylvania 19002), TAVOTEK BIOTHERAPEUTICS (HONG KONG) LIMITED (Unit 1, 9/F, Wo Hing Commercial Building,11 Wing Wo StreetCentral) filed a patent application (PCT/US2025/020406) for "ANTIBODIES TARGETING CD318 (CDCP1) AND USES THEREOF" on Mar 18, 2025. With publication no. WO/2025/199124, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Di (c/o Tavotek Lab Inc727 Norristown Rd,3 Spring House Innovation Park...